Arena Pharmaceuticals (ARNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -616,433 | -460,824 | -264,512 | -118,417 | -404,734 |
| Depreciation Amortization | 8,119 | 6,138 | 4,171 | 2,087 | 5,408 |
| Accounts receivable | 1,101 | 1,014 | 1,053 | -379 | 344 |
| Other Working Capital | 23,179 | 10,155 | 22,305 | -8,465 | -1,487 |
| Other Operating Activity | 132,018 | 111,997 | 23,156 | 5,185 | 47,375 |
| Operating Cash Flow | $-452,016 | $-331,520 | $-213,827 | $-119,989 | $-353,094 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -988 | -455 | -302 | -97 | -820 |
| Purchase Of Investment | -612,218 | -410,316 | -270,683 | -161,178 | -1,033,665 |
| Sale Of Investment | 1,004,607 | 853,089 | 660,685 | 388,385 | 1,014,083 |
| Other Investing Activity | -70,000 | -70,000 | 0 | 0 | -1,000 |
| Investing Cash Flow | $321,401 | $372,318 | $389,700 | $227,110 | $-21,402 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -4,401 | -3,243 | -2,113 | -1,027 | -3,815 |
| Common Stock Issued | 139,808 | 129,524 | 120,930 | 107,420 | 354,421 |
| Financing Cash Flow | $135,407 | $126,281 | $118,817 | $106,393 | $350,606 |
| Exchange Rate Effect | 236 | 30 | -57 | -80 | 160 |
| Beginning Cash Position | 219,770 | 219,770 | 219,770 | 219,770 | 243,500 |
| End Cash Position | 224,798 | 386,879 | 514,403 | 433,204 | 219,770 |
| Net Cash Flow | $5,028 | $167,109 | $294,633 | $213,434 | $-23,730 |
| Free Cash Flow | |||||
| Operating Cash Flow | -452,016 | -331,520 | -213,827 | -119,989 | -353,094 |
| Capital Expenditure | -988 | -455 | -302 | -97 | -820 |
| Free Cash Flow | -453,004 | -331,975 | -214,129 | -120,086 | -353,914 |